Shaw L J, Tarkington L, Callister T, Murgo J, Simon A, Waller C, Battaglia S, Mangione N, Chambers J, Smart F, Mehta S, Anderson A, Kugelmass A, Raggi P, Houser F
Department of Quality, Clinical Cardiovascular Management Network, HCA The Healthcare Company, Nashville, TN, USA.
Am J Manag Care. 2001 Sep 25;7 Spec No:SP25-30.
The diagnosis and treatment of heart disease in women continues to be one of the greatest challenges facing cardiovascular medicine today. Marked reductions in mortality rates during the past 2 decades did not result in improved outcomes for women. A major rate-limiting step to improving mortality rates for women is early diagnosis and initiation of effective lifesaving therapies for women. In 1999, HCA Healthcare Systems, Inc, Nashville, TN, initiated a coordinated effort among 208 hospitals in 26 states to improve the diagnosis of coronary disease and to target women who should receive aggressive risk factor modification and referral to cardiologists. We describe the initial phases of program development, including employee risk factor screening; citywide health risk assessment; nationwide educational programs for clinicians, staff, and consumers; and a dedicated outcomes assessment program for tracking women at risk for coronary disease. We believe that these efforts provide a venue for optimal care and improved outcomes for women served by HCA facilities.
女性心脏病的诊断和治疗仍然是当今心血管医学面临的最大挑战之一。在过去20年中死亡率显著降低，但并未改善女性患者的治疗结果。提高女性死亡率的一个主要限速步骤是早期诊断并为女性启动有效的挽救生命的治疗。1999年，位于田纳西州纳什维尔的HCA医疗保健系统公司在26个州的208家医院之间发起了一项协同努力，以改善冠心病的诊断，并针对那些应接受积极危险因素调整并转诊至心脏病专家处的女性。我们描述了项目开发的初始阶段，包括员工危险因素筛查；全市范围的健康风险评估；针对临床医生、工作人员和消费者的全国性教育项目；以及一个专门的结果评估项目，用于追踪有冠心病风险的女性。我们相信，这些努力为HCA医疗机构所服务的女性提供了获得最佳护理和改善治疗结果的途径。
